Therapeutics Daily (subscription) (press release), PA -Eisai acquired four cancer-related drugs from the California-based Ligand Pharmaceuticals Inc. last year and continues to conduct clinical trials on its own ...<br><img src="/images/chart_7777cc3.gif" class="ticker-icon" width="14" height="12"><a href="http://finance.google.com/finance?q=OTC:ESALY&client=news" class="rich">OTC:ESALY</a><a href="http://www.monitor.co.ug/business/bus07071.php" id=r-1i_0><img src=http://news.google.com/news?imgefp=0UI5N6OTSzwJ&imgurl=www.monitor.co.ug/images/business/bus07071.jpg width=62 height=80 alt="" border=1></a><a href="http://www.monitor.co.ug/business/bus07071.php" id=r-1_0>URA exempts 448 firms</a><br>The Monitor, Uganda, Uganda - 21 minutes ago<br>Oil companies like Shell, Caltex and Heritage, manufacturing industries like Nice House of Plastics, Mukwano and Bidco, pharmaceuticals and construction ...

::Read the Full Article